Breaking news
The dance floor in Degerfors folk park burned down -
Leader: Time to clean up the swamp of rules -
Big fire in Folkets park in Degerfors | Sweden -
For sale: Tires | Happyride.se -
Man arrested for several arson attacks -
“We should accelerate Russia’s collapse” -
Buy: S-works Epic or Epic Evo. -

Attana is entering the third year of a five-year service and support contract from a leading healthcare institute in the United States

Attana is entering the third year of a five-year service and support contract from a leading healthcare institute in the United States
Attana is entering the third year of a five-year service and support contract from a leading healthcare institute in the United States
--

The contract is now entering its third year and it is an important part of the company’s plan to establish strong reference customers in the USA. In the past year, several users have been trained in Attana’s technology, and studies of T-cell interactions with animal cancer cells are currently underway. The hope is that the data from the experiments will be published in the autumn and that the project will then also be carried out on cancer biopsies.

The value of the service agreement is just over SEK 200,000 per year and to that is added the sale of the sensor chip and associated consumables.

The customer is an important part in establishing strong reference customers in the USA. The nature of the projects are chosen so that, upon completion, they will clearly highlight the advantages and value creation of Attana technology compared to traditional methods. Since the experiments with the customer in question go hand in hand with clinical studies and animal experiments, the project runs for a total of five years and is now about halfway through.

For further information, contact:

Teodor Aastrup

CEO Attana AB
[email protected]

+46 708862300

The board fr Attana AB bedomer that the information in this press release is notr off coursevacknowledging characterr but that anywaymt är of significant importance to publish uniformly viarand communicate the information to the company’s stakeholders.

About Attana

Attana AB was founded in 2002 with the idea of ​​streamlining research and development of new drugs through biological interaction characterization in real time. Based on its patented technologies, the company sells commissioned research and self-produced analysis instruments as well as a in vitro diagnostic (IVD) tool, Attana Virus Analytics (AVA), to pharmaceutical companies, biotechnology companies and academic institutions. More information about Attana’s research services and products is available at www.attana.com or contact [email protected]

The article is in Swedish

Tags: Attana entering year fiveyear service support contract leading healthcare institute United States

-

NEXT Saga Cavallin: Comic ads show holes in surveillance